BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis Regulators
Renju Pun,
No information about this author
Aradhana Thapa,
No information about this author
S. Takafuji
No information about this author
et al.
Journal of the American Heart Association,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 7, 2025
Congenital
heart
defects
are
structural
anomalies
present
at
birth
that
can
affect
the
function
of
heart.
Aneuploidy
is
a
significant
risk
factor
for
congenital
defects.
Mosaic
variegated
aneuploidy
syndrome,
caused
by
mutations
in
Bub1b
(encoding
BubR1,
mitotic
checkpoint
protein),
leads
to
such
as
septal
However,
molecular
rationale
how
promote
associated
with
mosaic
syndrome
remains
unresolved.
To
study
morphological,
structural,
and
cellular
consequences
BubR1
deletion
heart,
we
crossed
mice
carrying
conditional
alleles
Nkx2.5-cre
mice.
Single-cell
RNA
sequencing
was
carried
out
determine
differentially
expressed
genes
biological
processes
various
cell
types
developing
Trajectory
analysis
differentiation
trajectory
knockout
embryonic
hearts.
Finally,
CellChat
provided
details
on
major
signaling
interactions
were
either
absent
or
hyperactive
Here,
show
cardiac-specific
causes
lethality
due
developmental
stalling
after
cardiac
looping
maturation
including
chamber
wall
thickness,
septation,
trabeculation.
transcriptomic
profiling
further
revealed
cardiomyocytes
severely
impacted
suppression
critical
cardiogenesis
genes.
Hyperactivation
Wnt
hearts
indicated
disturbed
homeostasis
pathways
essential
proper
tissue
morphogenesis
Taken
together,
these
findings
reveal
crucial
regulator
development
vivo,
which
ensures
timing
morphogenesis.
Language: Английский
Knockdown of TGFB2 Attenuates Ischemic Heart Failure by Inhibiting Apoptosis
Zheng Yang,
No information about this author
Cong Ye,
No information about this author
Haitao Li
No information about this author
et al.
Cardiovascular Toxicology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
Language: Английский
STAT3 expression is reduced in cardiac pericytes in HFpEF and its loss reduces cellular adhesion and induces pericyte senescence
Leah Rebecca Vanicek,
No information about this author
Ariane Fischer,
No information about this author
Mariano Ruz Jurado
No information about this author
et al.
FEBS Letters,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 1, 2025
Heart
failure
with
preserved
ejection
fraction
(HFpEF)
accounts
for
half
of
heart
cases
and
is
characterised
by
reduced
pericyte
coverage.
While
the
contributions
other
cardiac
cell
types
to
HFpEF
are
well-studied,
role
pericytes
remains
less
understood.
Using
murine
single-nucleus
RNA-sequencing
study
in
HFpEF,
we
identified
STAT3
expression
as
a
hallmark
pericytes.
Mechanistic
studies
vitro
revealed
that
deletion
induces
cellular
senescence
impairs
adhesion,
recapitulating
HFpEF-like
characteristics.
These
findings
suggest
crucial
maintaining
homeostasis
highlight
its
reduction
potential
driver
loss,
defining
feature
HFpEF.
Language: Английский
Keeps Cardiac Pericytes in Good Shape: Regulator of G-Protein Signaling-5
Circulation Research,
Journal Year:
2024,
Volume and Issue:
134(10), P. 1256 - 1258
Published: May 9, 2024
Language: Английский
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fraction
Valeria Vincenza Alvino,
No information about this author
Sadie C. Slater,
No information about this author
Yan Qiu
No information about this author
et al.
Cardiovascular Diabetology,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Nov. 5, 2024
Abstract
Aims
Aging
is
influenced
by
genetic
determinants
and
comorbidities,
among
which
diabetes
increases
the
risk
for
heart
failure
with
preserved
ejection
fraction.
There
no
therapy
to
prevent
dysfunction
in
aging
diabetic
individuals.
In
previous
studies,
a
single
administration
of
longevity-associated
variant
(LAV)
human
BPIFB4
gene
halted
decline
older
type
2
mice.
Here,
we
asked
whether
orally
administered
LAV-BPIFB4
protein
replicates
these
benefits.
Materials
Methods
two
controlled,
randomized
18-month-old
male
C57BL/6
J
mice
9-week-old
C57BLKS/J-Leprdb/Leprdb/Dock7
+
[db/db]
both
sexes
underwent
baseline
echocardiography.
They
then
received
recombinant
purified
(3
µg/animal,
every
three
days)
or
vehicle
gavage.
After
30
days,
animals
echocardiography,
hearts
were
collected
post-termination
histology.
Results
All
completed
study
except
one
female
mouse,
was
culled
prematurely
because
tooth
malocclusion
caused
eating
problems.
effect
on
body
weight
studies
glycosuria
study.
mice,
increased
myocardial
Bpifb4
expression,
improving
contractility
capillarity
while
reducing
perivascular
fibrosis
senesce.
improved
systolic
function,
microvascular
density,
senescence,
whereas
benefit
limited
function
females.
Conclusions
This
shows
feasibility
efficacy
associated
longevity
contrasting
pivotal
factors
animal
models.
The
revealed
that
sex
influences
treatment
efficacy.
Language: Английский
Ershen Zhenwu Decoction Suppresses Myocardial Fibrosis of Chronic Heart Failure with Heart–Kidney Yang Deficiency by Down-Regulating the Ras Homolog Gene Family Member A/Rho-Associated Coiled-Coil Kinases Signaling Pathway
Dan Cheng,
No information about this author
Sheng Sheng,
No information about this author
Jing Hu
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2024,
Volume and Issue:
340, P. 119146 - 119146
Published: Nov. 22, 2024
Language: Английский
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fraction
Valeria Vincenza Alvino,
No information about this author
Sadie C. Slater,
No information about this author
Yan Qiu
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 16, 2024
Abstract
Aims:
Aging
is
influenced
by
genetic
determinants
and
comorbidities,
among
which
diabetes
increases
the
risk
for
heart
failure
with
preserved
ejection
fraction.
There
no
therapy
to
prevent
dysfunction
in
ageing
diabetic
individuals.
In
previous
studies,
a
single
administration
of
longevity-associated
variant
(LAV)
human
BPIFB4
gene
halted
decline
older
type-2
mice.
Here,
we
asked
whether
orally
administered
LAV-BPIFB4
protein
replicates
these
benefits.
Materials
Methods.In
two
controlled,
randomized
18-month-old
male
C57BL/6J
mice
9-week-old
C57BLKS/J-Leprdb/Leprdb/Dock7+
[db/db]
both
sexes
underwent
baseline
echocardiography.
They
then
received
recombinant
purified
(3
µg/animal,
every
three
days)
or
vehicle
gavage.
After
30-day,
animals
echocardiography
hearts
were
collected
post-termination
histology.
Results.
All
completed
study
except
one
female
mouse,
was
culled
prematurely
because
tooth
malocclusion,
caused
eating
problems.
effect
on
body
weight
studies
glycosuria
study.
aging
mice,
increased
myocardial
BPIFB4
expression,
improving
contractility
capillarity
while
reducing
perivascular
fibrosis
senesce.
improved
systolic
function,
microvascular
density,
senescence,
whereas
benefit
limited
function
females.
Conclusions.
This
shows
feasibility
efficacy
associated
longevity
contrasting
pivotal
factors
animal
models.
The
revealed
that
sex
influences
treatment
efficacy.
Language: Английский
The aging heart: exploring the role of Klotho in cardiac health/function
The Journal of Cardiovascular Aging,
Journal Year:
2024,
Volume and Issue:
4(4)
Published: Dec. 20, 2024
This
review
discusses
the
pathophysiological
changes
associated
with
cardiac
aging
and
potential
therapeutic
role
of
anti-aging
protein
Klotho.
It
highlights
key
contributors
to
heart
failure,
such
as
arterial
stiffening,
myocardial
fibrosis,
impaired
relaxation,
all
which
lead
declining
function
heart.
also
explores
regulation
Klotho
expression,
its
various
forms,
impact
on
health,
emphasizing
protective
roles
against
oxidative
stress,
inflammation,
remodeling.
Klotho's
a
target
for
mitigating
improving
cardiovascular
health
in
elderly
is
central
theme,
making
it
promising
candidate
future
interventions
aimed
at
enhancing
longevity.
Language: Английский